We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00720408
Recruitment Status : Completed
First Posted : July 22, 2008
Last Update Posted : September 15, 2009
Astellas Pharma Taiwan, Inc.
Information provided by:
Astellas Pharma Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2009
  Study Completion Date : September 2009